Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2026
DLL3 Expression in a Genotyped Cohort of Sporadic Medullary Thyroid Carcinomas.
Journal: The American journal of surgical pathology
Published: March 13, 2026
DLL3 Expression in a Genotyped Cohort of Sporadic Medullary Thyroid Carcinomas.
Journal: The American journal of surgical pathology
Published: March 13, 2026
Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial.
Journal: Nature communications
Published: January 29, 2026
The ceiling effect of heart failure pharmacotherapy in acute left ventricular recovery for patients with atrial fibrillation-mediated cardiomyopathy prior to rhythm control.
Journal: Heart rhythm
Published: September 02, 2025
A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 14, 2025
Personalized Thyroidology: Molecular Rewiring of Thyroid Nodule Management.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 31, 2025
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 23, 2025
Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: July 01, 2025
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer.
Journal: Nature communications
Published: January 21, 2025
A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 16, 2024
Last Updated: 09/26/2026